頭頸癌藥物市場按藥物類別、銷售管道和地區分類

Head and Neck Cancer Drugs Market, By Drug Class, By Sales Channel, and By Geography

出版日期: 2025年07月15日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

頭頸癌治療市場規模預計在 2025 年達到 22.866 億美元，預計到 2032 年將達到 37.445 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	22.866億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	7.30%	2032年價值預測	37.445億美元

頭頸癌是一個醫學術語，指發生在鼻腔、咽喉、鼻竇、喉頭和口腔周圍的各種惡性腫瘤。大多數頭頸癌是鱗狀細胞癌。如果及早發現，頭頸癌的治癒率很高，但治療效果取決於多種因素。

市場動態

頭頸癌負擔的增加、對疾病診斷的日益關注、吸煙、飲酒和重度飲酒的增加、對安全有效的藥物和治療的需求增加以及研發的增加是預計將促進全球頭頸癌治療市場成長的主要因素。

例如，2022年2月，辛辛那提大學的研究人員啟動了一項新的臨床試驗，以檢驗局部放射療法與免疫療法相結合是否可以更好地治療方法復發性頭頸癌患者。

此外，2021年2月，美國FDA授予Kura Oncology公司開發的替比法尼（tipifarnib）突破性療法認定，用於治療頭頸部鱗狀細胞癌（HNSCC）。該藥物是一種強效選擇性口服藥物。

本次調查的主要特點

本報告對全球頭頸癌治療市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模（百萬美元）和年複合成長率(CAGR)。
它還強調了各個領域的潛在商機，並說明了針對該市場的引人注目的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
該報告根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球頭頸癌藥物市場的主要企業進行了概述。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
全球頭頸癌藥物市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球頭頸癌治療市場的各種策略矩陣，相關人員將更容易做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2,286.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 3,744.5 Mn

Head and neck cancer is a medical term used to describe different malignant tumors that develop in or around the nose, throat, sinuses, larynx, and mouth. Most head and neck cancers are squamous cell carcinomas. Head and neck cancer is highly curable if detected early, however, the treatment depends on a number of factors.

Market Dynamics

Growing burden of head and neck cancer, rise in focus on disease diagnosis, increase in cigarette smoking, alcohol consumption, and high use of tobacco, high demand for safe and effective drugs or treatment, and increasing research and development are major factors expected to augment the growth of the global head and neck cancer drugs market.

For instance, in February 2022, University of Cincinnati researchers launched a new clinical trial to examine if the combination of a localized radiation treatment and immunotherapy can be a better treatment for patients with recurrent head and neck cancer.

Moreover, in February 2021, the U.S. FDA granted breakthrough therapy designation to Tipifarnib developed by Kura Oncology, Inc., for the treatment of patients with head and neck squamous cell carcinoma (HNSCC). This is a potent, selective, and orally administered drug.

Key features of the study

This report provides in-depth analysis of the global head and neck cancer drugs market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global head and neck cancer drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech, Inc.,), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global head and neck cancer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global head and neck cancer drugs market.

Market Segmentation

Global Head and Neck Cancer Drugs Market, By Drug Class
- Chemotherapy
- Immunotherapy
- Targeted Therapy
Global Head and Neck Cancer Drugs Market, By Sales Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Stores
Global Head and Neck Cancer Drugs Market, By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Merck & Co., Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Astrazeneca Plc.
- Fresenius Medical Care AG & CO. KGAA
- F.Hoffmann-la Roche Ltd. (Genentech, Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Sales Channel
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of head and neck cancer
- Adverse effects of head and neck cancer drugs
- Increasing demand for safe and effective drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Head and Neck Cancer Drugs Market, By Drug Class, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

5. Global Head and Neck Cancer Drugs Market, By Sales Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Drug Stores & Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

6. Global Head and Neck Cancer Drugs Market, By Geography, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(USD Mn) Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astrazeneca Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Medical Care AG & CO. KGAA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-la Roche Ltd. (Genentech, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views